Related Experiment Video
Updated: Aug 8, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins
Kelly J Higgins1, Maen Abdelrahim, Shengxi Liu
1Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, USA.
Abstract:
Vascular endothelial growth factor receptor-2 (VEGFR2/KDR) is an important mediator of angiogenesis, and VEGFR2 mRNA is expressed in several pancreatic cancer cell lines. Deletion analysis of the VEGFR2 promoter in Panc-1, AsPC-1, and MiaPaCa-2 pancreatic cancer cells shows that the proximal region of the promoter is primarily responsible for VEGFR2 expression, and two GC-rich sites at -58 and -44 are critical elements in all three cell lines. Panc-1, AsPC-1, and MiaPaCa-2 cells also express Sp1, Sp3, and Sp4 proteins which bind to the GC-rich region of the VEGFR2 promoter in electrophoretic mobility shift and chromatin immunoprecipitation assays. RNA interference with small inhibitory RNAs for Sp1, Sp3, and Sp4 decreases VEGFR2 mRNA and reporter gene activity in transfection assays, confirming that VEGFR2 expression in pancreatic cancer cells is regulated by Sp proteins. These results suggest that VEGFR2 cannot only be targeted by receptor tyrosine kinase inhibitors but also by drugs that downregulate Sp proteins or block Sp-dependent transactivation.
Insights
Vascular endothelial growth factor receptor-2 (VEGFR2) is crucial for pancreatic cancer angiogenesis. Sp proteins regulate VEGFR2 expression, offering new therapeutic targets beyond receptor tyrosine kinase inhibitors.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Vascular endothelial growth factor receptor-2 (VEGFR2/KDR) plays a key role in angiogenesis.
- VEGFR2 mRNA is detected in pancreatic cancer cell lines, suggesting its involvement in tumor progression.
Purpose of the Study:
- To investigate the regulatory mechanisms of VEGFR2 expression in pancreatic cancer cells.
- To identify specific DNA elements and transcription factors involved in VEGFR2 gene regulation.
Main Methods:
- Deletion analysis of the VEGFR2 promoter in pancreatic cancer cell lines (Panc-1, AsPC-1, MiaPaCa-2).
- Electrophoretic mobility shift assays (EMSA) and chromatin immunoprecipitation (ChIP) to assess protein-DNA interactions.
- RNA interference (RNAi) to evaluate the functional role of Sp proteins in VEGFR2 expression.
Main Results:
- The proximal region of the VEGFR2 promoter, particularly GC-rich sites at -58 and -44, is critical for expression in pancreatic cancer cells.
- Sp1, Sp3, and Sp4 proteins bind to these GC-rich sites.
- Downregulation of Sp proteins via RNAi significantly reduces VEGFR2 mRNA levels and reporter gene activity.
Conclusions:
- VEGFR2 expression in pancreatic cancer cells is regulated by Sp1, Sp3, and Sp4 transcription factors.
- Targeting Sp proteins or their interaction with the VEGFR2 promoter represents a potential therapeutic strategy for pancreatic cancer, complementing existing VEGFR2-targeted therapies.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Cell Specific Gene Expression
